Boston Scientific Corporation
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Boston Scientific Corporation
RECRUITINGNCT06510556
Feasibility Study of the FARAFLEX Mapping and PFA System
The objective of this feasibility study is to evaluate the safety and effectiveness of the FARAFLEX mapping and pulsed field ablation (PFA) catheter, a novel catheter in treating...
Sponsor: Boston Scientific CorporationEnrolling: 2504 locations
Atrial FibrillationPersistent Atrial FibrillationParoxysmal AF
RECRUITINGNCT06808217
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter...
The study is designed to collect data on the acute and long-term (1 year) safety and effectiveness outcome when an ablation procedure is performed in a commercial and standard of...
Sponsor: Boston Scientific CorporationEnrolling: 50020 locations
Atrial FibrillationPulsed Field AblationFARAPULSE
RECRUITINGNCT07106970
PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)
This study is a prospective, multicenter, open-label, randomized controlled trial to investigate whether a linear ablation in addition to pulmonary vein isolation (PVI)...
Sponsor: Boston Scientific CorporationEnrolling: 6401 location
Persistent Atrial Fibrillation